Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Magdalena Pluta
Observed names:
M. Pluta,
Magdalena PLUTA
Institution:
Medical University of Warsaw
Observed institution:
Medical University of Warsaw
ORCID:
0000-0003-1139-1302
Observed ORCID:
0000-0003-1139-1302
OpenAlex ID:
A5070033599
High Rates of Prescribing Antimicrobials for Prophylaxis in Children and Neonates: Results From the Antibiotic Resistance and Prescribing in European Children Point Prevalence Survey
2018
·
Markus Hufnagel
, Ann Versporten
, et al.
·
Journal of the Pediatric Infectious Diseases Society
·
62
Efficacy and safety of treatment with sofosbuvir/velpatasvir in patients aged 6–18 years with chronic hepatitis C—Results of the PANDAA‐PED study
2023
·
Maria Pokorska‐Śpiewak
, Ewa Talarek
, et al.
·
Liver International
·
21
PDF
Novel serum biomarkers modified by the body mass index z-score for the detection of liver fibrosis and steatosis in children with chronic hepatitis C
2017
·
Maria Pokorska-Śpiewak
, Barbara Kowalik-Mikołajewska
, et al.
·
BMC Infectious Diseases
·
18
PDF
Liver steatosis in children with chronic hepatitis B and C: Prevalence, predictors, and impact on disease progression
2017
·
Maria Pokorska-Śpiewak
, Barbara Kowalik-Mikołajewska
, et al.
·
Medicine
·
18
Hepatitis C infection among pregnant women in central Poland: Significance of epidemiological anamnesis and impact of screening tests to detect infection
2019
·
Małgorzata Aniszewska
, Maria Pokorska-Śpiewak
, et al.
·
Advances in Clinical and Experimental Medicine
·
14
PDF
Determinants of liver disease progression in children with chronic hepatitis C virus infection
2016
·
Maria Pokorska-Śpiewak
, Barbara Kowalik-Mikołajewska
, et al.
·
Polish Journal of Pathology
·
13
PDF
Non-invasive evaluation of the liver disease severity in children with chronic viral hepatitis using FibroTest and ActiTest – comparison with histopathological assessment
2017
·
Maria Pokorska-Śpiewak
, Barbara Kowalik-Mikołajewska
, et al.
·
Clinical and Experimental Hepatology
·
9
PDF
Viral Suppression, Viral Failure, and Safety Outcomes in Children and Adolescents With HIV on Dolutegravir in Europe and Thailand
2025
·
Karen Scott
, John O’Rourke
, et al.
·
Clinical Infectious Diseases
·
7
PDF
Health‐related quality of life in patients aged 6–18 years with chronic hepatitis C treated with sofosbuvir/velpatasvir
2023
·
Maria Pokorska‐Śpiewak
, Ewa Talarek
, et al.
·
Liver International
·
7
Clinical usefulness of new noninvasive serum biomarkers for the assessment of liver fibrosis and steatosis in children with chronic hepatitis C
2017
·
Maria Pokorska-Śpiewak
, Barbara Kowalik-Mikołajewska
, et al.
·
Clinical and Experimental Hepatology
·
7
PDF
Ukrainian War Refugee Children With Particularly Severe Viral Infections: A Case Series Report
2023
·
Magdalena Pluta
, Katarzyna Karny
, et al.
·
The Pediatric Infectious Disease Journal
·
6
Progress and Barriers Towards Elimination of Chronic Hepatitis C in Children
2020
·
Magdalena Pluta
, Maria Pokorska-Śpiewak
, et al.
·
Klinische Pädiatrie
·
5
Predictors of Liver Disease Severity in Children with Chronic Hepatitis B
2016
·
Maria Pokorska-Śpiewak
, Barbara Kowalik-Mikołajewska
, et al.
·
Advances in Clinical and Experimental Medicine
·
4
PDF
Facial nerve palsy in the course of herpes zoster infection – challenges in the treatment and prognosis
2021
·
Maja Pietrzak
, Maria Śpiewak-Pokorska
, et al.
·
Pediatria Polska
·
3
PDF
Acute Hepatitis B and Unusual Follow-Up in a 16-Year-Old Boy: Case Report
2021
·
Carlo Bieńkowski
, Monika Kowalczyk
, et al.
·
Pediatric Reports
·
3
PDF
The Influence of Treatment With Sofosbuvir/Velpatasvir on Children’s Growth—Results of the PANDAA-PED Study
2024
·
Maria Pokorska-Śpiewak
, Ewa Talarek
, et al.
·
The Pediatric Infectious Disease Journal
·
2
Changes in Body Mass Index in Children and Adolescents Living With Human Immunodeficiency Virus in Europe and Thailand Starting Dolutegravir
2025
·
Elizabeth Chappell
, Siobhan Crichton
, et al.
·
Open Forum Infectious Diseases
·
1
PDF
Changes in liver stiffness and steatosis in children after successful treatment with sofosbuvir/velpatasvir: Results of the PANDAA-PED study
2025
·
Maria Pokorska-Śpiewak
, Ewa Talarek
, et al.
·
Clinical and Experimental Hepatology
·
1
PDF
THU-403 Liver fibrosis and steatosis in children after effective treatment of chronic hepatitis C using direct acting antivirals
2024
·
Maria Pokorska-Śpiewak
, Ewa Talarek
, et al.
·
Journal of Hepatology
·
1
Meningitis in the Course of Herpes Zoster Ophthalmicus in an Immunocompetent Boy
2023
·
Maja K. Pietrzak
, Magdalena Pluta
, et al.
·
The Pediatric Infectious Disease Journal
·
1
Pruritic, Bizarre Tracks- A Vacation Souvenir
2017
·
Magdalena Pluta
, Małgorzata Aniszewska
, et al.
·
Klinische Pädiatrie
·
1
Schistosomiasis in a child presenting with atypical spinal lesions in a non-endemic country — a case report
2025
·
Jakub Niestępski
, Hanna Żarnowska-Prymek
, et al.
·
International Maritime Health
Health-related Quality of Life in Children and Adolescents After Successful Treatment of Chronic Hepatitis C With Sofosbuvir/Velpatasvir: One-year Outcomes
2024
·
Maria Pokorska-Śpiewak
, Anna Dobrzeniecka
, et al.
·
The Pediatric Infectious Disease Journal
THU-387 Safety and efficacy of two pangenotypic direct acting antivirals (sofosbuvir/velpatasvir and glecaprevir/pibrentasvir) for the treatment of hepatitis C in children
2024
·
Maria Pokorska-Śpiewak
, Ewa Talarek
, et al.
·
Journal of Hepatology
Pediatria. Tom 1
2024
·
Ewa Adamska
, Inga Adamska
, et al.
Show more works
View as search
Works count:
34
Citation count:
204
H-index:
7
I10-index:
6
Year
Topic
Type